Resistance to third-generation cephalosporins in human non-typhoidal Salmonella enterica isolates from England and Wales, 2010-12

Journal of Antimicrobial Chemotherapy

Volumn 69, Issue 4, 2014, Pages 977-981

  Burke, Liam ^a   Hopkins, Katie L ^b   Meunier, Daniele ^b   De Pinna, Elizabeth ^b   Fitzgerald Hughes, Deirdre ^a   Humphreys, Hilary ^a   Woodford, Neil ^b  

^a BEAUMONT HOSPITAL   (Ireland)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

AmpCs; ESBLs; Surveillance

Indexed keywords

BETA LACTAMASE AMPC; BETA LACTAMASE CTX M; BETA LACTAMASE GES; BETA LACTAMASE PER; BETA LACTAMASE SHV; BETA LACTAMASE TEM; BETA LACTAMASE VEB; CARBAPENEM; CEFOTAXIME; CIPROFLOXACIN; ERTAPENEM; UNCLASSIFIED DRUG;

ALLELE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CONTROLLED STUDY; DRUG SCREENING; GENE IDENTIFICATION; GENE SEQUENCE; GENOTYPE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; SALMONELLA ENTERICA; SEROTYPE; UNITED KINGDOM;

AMPCS; ESBLS; SURVEILLANCE;

ALLELES; ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CEFOTAXIME; CEPHALOSPORINS; DNA, BACTERIAL; ENGLAND; HUMANS; MICROBIAL SENSITIVITY TESTS; PREVALENCE; SALMONELLA ENTERICA; SALMONELLA INFECTIONS; SALMONELLA INFECTIONS, ANIMAL; SEQUENCE ANALYSIS, DNA; WALES;

EID: 84896468494     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt469     Document Type: Article

References (27)

1. Miriagou V, Tassios PT, Legakis NJ et al. Expanded-spectrum cephalosporin resistance in non-typhoid Salmonella. Int J Antimicrob Agents 2004; 23: 547-55.
2. Piddock LJ. Fluoroquinolone resistance in Salmonella serovars isolated from humans and food animals. FEMS Microbiol Rev 2002; 26: 3-16.
3. CTX-M genes in clinical Salmonella isolates recovered from humans in England and Wales from 1992 to 2003. Antimicrob Agents Chemother 2005; 49: 1319-22.
4. Batchelor M, Hopkins KL, Threlfall EJ et al. Characterization of AmpC-mediated resistance in clinical Salmonella isolates recovered from humans during the period 1992 to 2003 in England and Wales. J Clin Microbiol 2005; 43: 2261-5.
5. Savard P, Gopinath R, Zhu W et al. First NDM-positive Salmonella sp. strain identified in the United States. Antimicrob Agents Chemother 2011; 55: 5957-8.
6. Miriagou V, Tzouvelekis LS, Rossiter S et al. Imipenem resistance in a Salmonella clinical strain due to plasmid-mediated class A carbapenemase KPC-2. Antimicrob Agents Chemother 2003; 47: 1297-300.
7. Le Hello S, Harrois D, Bouchrif B et al. Highly drug-resistant Salmonella enterica serotype Kentucky ST198-X1: a microbiological study. Lancet Infect Dis 2013; 13: 672-9.
8. Walker RA, Lindsay E, Woodward MJ et al. Variation in clonality and enterica-resistance genes among multiresistant Salmonella enterica serotype Typhimurium phage-typeU302(MRU302)fromhumans,animals, and foods. Microb Drug Resist 2001; 7: 13-21.
9. Lolans K, Calvert K, Won S et al. Direct ertapenem disk screening method for identification of KPC-producing Klebsiella pneumoniae and Escherichia coli in surveillance swab specimens. J Clin Microbiol 2010; 48: 836-41.
10. European Food Safety Authority and the European Centre for Disease Prevention and Control. The European Union Summary Report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2010. EFSA Journal 2012; 10: 2598.
11. CTX-M-1 and qnr genes in Escherichia coli and Salmonella from animals, the environment and humans. J Antimicrob Chemother 2013; 68: 333-9.
12. Liebana E, Carattoli A, Coque TM et al. Public health risks of enterobacterial isolates producing extended-spectrum β-Lactamases or AmpC β-Lactamases in food and food-producing animals: an EU perspective of epidemiology, analytical methods, risk factors, and control options. Clin Infect Dis 2013; 56: 1030-7.
13. CTX-M-1 in Salmonella enterica isolates from poultry and humans in France, 2003 to 2008. Antimicrob Agents Chemother 2010; 54: 4484-6.
14. Kiratisin P, Apisarnthanarak A, Saifon P et al. The emergence of a novel ceftazidime-resistant CTX-M extended-spectrum β-lactamase, CTX-M-55, in both community-onset and hospital-acquired infections in Thailand. Diagn Microbiol Infect Dis 2007; 58: 349-55.
15. Ho PL, Chow KH, Lai EL et al. Extensive dissemination of CTX-M-producing Escherichia coli with multidrug resistance to 'critically important' antibiotics among food animals in Hong Kong, 2008-10. J Antimicrob Chemother 2011; 66: 765-8.
16. Menezes GA, Khan MA, Harish BN et al. Molecular characterization of antimicrobial resistance in non-typhoidal salmonellae associated with systemic manifestations from India. J Med Microbiol 2010; 59: 1477-83.
17. Su LH, Chiu CH, Chu Cet al. In vivo acquisition of ceftriaxone resistance in Salmonella enterica serotype Anatum. Antimicrob Agents Chemother 2003; 47: 563-7.
18. Bertrand S, Weill FX, Cloeckaert A et al. Clonal emergence of extended-spectrum β-lactamase (CTX-M-2)-producing Salmonella enterica serovar Virchow isolates with reduced susceptibilities to ciprofloxacin among poultry and humans in Belgium and France (2000 to 2003). J Clin Microbiol 2006; 44: 2897-903.
19. CTX-M-9 from Escherichia coli and Salmonella enterica strains isolated from poultry and humans. Antimicrob Agents Chemother 2007; 51: 4177-80.
20. Gonzalez-Sanz R, Herrera-Leon S, de la Fuente M et al. Emergence of extended-spectrum β-Lactamases and AmpC-type β-Lactamases in human Salmonella isolated in Spain from 2001 to 2005. J Antimicrob Chemother 2009; 64: 1181-6.
21. Hendriksen RS, Mikoleit M, Kornschober C et al. Emergence of multidrug-resistant Salmonella Concord infections in Europe and the United States in children adopted from Ethiopia, 2003-2007. Pediatr Infect Dis J 2009; 28: 814-8.
22. TEM-52 gene-carrying IncI1 plasmid in various Salmonella enterica serovars isolated from poultry and humans in Belgium and France between 2001 and 2005. Antimicrob Agents Chemother 2007; 51: 1872-5.
23. Cardinale E, Colbachini P, Perrier-Gros-Claude JD et al. Dual emergence in food and humans of a novel multiresistant serotype of Salmonella in Senegal: Salmonella enterica subsp. enterica serotype 35:c:1,2. J Clin Microbiol 2001; 39: 2373-4.
24. Whichard JM, Gay K, Stevenson JE et al. Human Salmonella and concurrent decreased susceptibility to quinolones and extendedspectrum cephalosporins. Emerg Infect Dis 2007; 13: 1681-8.
25. Hopkins KL, Day M, Threlfall EJ. Plasmid-mediated quinolone resistance in Salmonella enterica, United Kingdom. Emerg Infect Dis 2008; 14: 340-2.
26. Le Hello S, Hendriksen RS, Doublet B et al. International spread of an epidemic population of Salmonella enterica serotype Kentucky ST198 resistant to ciprofloxacin. J Infect Dis 2011; 204: 675-84.
27. Lee HY, Su LH, Tsai MH et al. High rate of reduced susceptibility to ciprofloxacin and ceftriaxone among nontyphoid Salmonella clinical isolates in Asia. Antimicrob Agents Chemother 2009; 53: 2696-9.